Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1679803 | 1.00 | GLO1 (0.56) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL12267708 | 0.94 | GLO1 (0.55) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL1679737 | 0.92 | GLO1 (0.48) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL1679736 | 0.92 | GLO1 (0.48) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL14959182 | 0.90 | GLO1 (0.47) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL11248624 | 0.89 | GLO1 (0.50) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL11248625 | 0.89 | GLO1 (0.50) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL5071854 | 0.88 | PTGS1 (0.55) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL11814501 | 0.88 | GLO1 (0.46) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL11814497 | 0.88 | GLO1 (0.46) | GLO1ALDH1A1LMNAHSD17B10NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11523610-B2 | Regulating plant growth using a diapocarotenoid | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2022-12-13 | — | — | US | disclosed |
| EP-1667954-B1 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2018-11-14 | — | — | EP | disclosed |
| EP-1487774-B1 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-1487774-A4 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | Diffusion Pharmaceuticals LLC (US) | 2018-04-25 | — | — | EP | disclosed |
| US-20170202798-A1 | BIPOLAR TRANS CARTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2017-07-20 | — | — | US | disclosed |
| US-20170202798-A1 | BIPOLAR TRANS CARTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2017-07-20 | — | — | US | disclosed |
| US-9604899-B2 | Bipolar trans carotenoid salts and their uses | DIFFUSION PHARMACEUTICALS LLC (US) | 2017-03-28 | — | — | US | disclosed |
| US-9604899-B2 | Bipolar trans carotenoid salts and their uses | DIFFUSION PHARMACEUTICALS LLC (US) | 2017-03-28 | — | — | US | disclosed |
| US-20140051759-A1 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2014-02-20 | — | — | US | disclosed |
| US-20140051759-A1 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2014-02-20 | — | — | US | disclosed |
| US-20070161610-A1 | Bipolar trans carotenoid salts and their uses | DIFFUSION PHARMACEUTICALS LLC (US) | 2007-07-12 | — | — | US | disclosed |
| US-20070161610-A1 | Bipolar trans carotenoid salts and their uses | DIFFUSION PHARMACEUTICALS LLC (US) | 2007-07-12 | — | — | US | disclosed |
| US-20070161610-A1 | Bipolar trans carotenoid salts and their uses | DIFFUSION PHARMACEUTICALS LLC (US) | 2007-07-12 | — | — | US | disclosed |
| EP-1667954-A4 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2006-12-20 | — | — | EP | disclosed |
| EP-1667954-A1 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | Diffusion Pharmaceuticals LLC (US) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005028411-A1 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2005-03-31 | — | — | WO | disclosed |
| EP-1487774-A2 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | Diffusion Pharmaceuticals LLC (US) | 2004-12-22 | — | — | EP | disclosed |
| US-20040116729-A1 | Bipolar trans carotenoid salts and their uses | DIFFUSION PHARMACEUTICALS LLC | 2004-06-17 | — | — | US | disclosed |
| US-20040014725-A1 | Biopolar trans carotenoid salts and their uses | DIFFUSION PHARMACEUTICALS LLC | 2004-01-22 | — | — | US | disclosed |
| WO-2003072734-A2 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | DIFFUSION PHARMACEUTICALS LLC (US) | 2003-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051759-A1 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES | RBP4, MB, SLC6A12 | GLO1 3914/4885ALDH1A1 3199/4885LMNA 1460/4885 |
| US-20070161610-A1 | Bipolar trans carotenoid salts and their uses | RBP4, MB, SLC6A12 | GLO1 3914/4885ALDH1A1 3199/4885LMNA 1460/4885 |
| US-20170202798-A1 | BIPOLAR TRANS CARTENOID SALTS AND THEIR USES | TXNRD2, CYP11B2, CYP11B1 | GLO1 4182/4885ALDH1A1 2608/4885LMNA 2225/4885 |
| US-20040014725-A1 | Biopolar trans carotenoid salts and their uses | GYS1, TXNRD3, SLC39A14 | GLO1 2039/4885ALDH1A1 3602/4885LMNA 2425/4885 |
| US-11523610-B2 | Regulating plant growth using a diapocarotenoid | RER1, GRHPR, ERH | GLO1 1832/4885ALDH1A1 282/4885LMNA 4066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.